THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

ALGERT GLOBAL LLC's Holding History (CIK: 0001275218)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 199,705 Value ($000) $3 Avg Close $12.64 Range $10.82 - $14.87

Q3 2024

Shares 105,609 Value ($000) $1 Avg Close $8.66 Range $7.44 - $10.42

Q3 2022

Shares 30,700 Value ($000) $311 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 69,890 Value ($000) $633 Avg Close $9.21 Range $8.15 - $10.52

Q1 2022

Shares 20,730 Value ($000) $198 Avg Close $9.80 Range $7.71 - $13.17

Q4 2021

Shares 31,730 Value ($000) $351 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 18,380 Value ($000) $136 Avg Close $11.19 Range $6.10 - $15.01

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	199,705	$3	$12.64	$10.82 - $14.87
Q3 2024	105,609	$1	$8.66	$7.44 - $10.42
Q3 2022	30,700	$311	$9.37	$7.53 - $11.00
Q2 2022	69,890	$633	$9.21	$8.15 - $10.52
Q1 2022	20,730	$198	$9.80	$7.71 - $13.17
Q4 2021	31,730	$351	$8.72	$7.30 - $11.24
Q3 2021	18,380	$136	$11.19	$6.10 - $15.01